Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
It’s back-to-school season, and several students are heading to the classroom with a little extra help on the financial side thanks to immunology drugmaker AbbVie. | Since its immunology scholarship was established in 2016, AbbVie has supported more than 350 students living with immunology conditions, with its investments in the program totaling more than $6 million.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a…

As AbbVie continues to capitalize on its deal for ImmunoGen with the growth of commercial antibody-drug conjugate (ADC) Elahere,…

AbbVie will acquire Apogee for $10.9 billion, adding late-stage immunology and asthma assets to its pipeline.

Abbott is again tapping into the competitive spirit of Big Ten universities to drive blood donations,

A year after a major layoff round at its Allergan Aesthetics headquarters in California, AbbVie is making more edits to its…

AbbVie strikes a $10.9B deal for Apogee, adding a long-acting IL-13 drug to its Humira-Skyrizi-Rinvoq I&I franchise.